Featured Opinions
The Swine Flu Pandemic of 2009: Much Ado About Nothing?
by Clifford M
The Swine Flu Pandemic of 2009: Much Ado About Nothing?
Time for DDMAC to move into the present
Social media, it's growing and its estimated that in the U.S. over 60% of all Internet users use social media to some extent.
SLEPT analysis - time to wake up
In uncertain econmic environments like we have now, the importance of strong environmental analysis is easy to appreciate.
The good, the bad and the ugly of word of mouth
by Anonymous (not verified)
Top 10 new pharma drugs: Best does not guarantee success
Interesting article in today's Business Week online on the ten most promising new pharma drugs.
Which is more important Sales Coaching vs. Admin? The Great Debate:
by Steven Rosen
It is very lonely in the world of blogging, so getting comments from clients is a validation that people are reading your thoughts.
The curious case of wrinkles, Botox and FDA
by Clifford M
One day after the US Food and Drug Administration (FDA) approved Dysport, a new product that will compete with Botox, the agency ordered that labels for all botulinal toxin-based drugs must carry a bl
Swine Flu pandemic: Many questions and few answers
by Clifford M
Vincent Racaniello, an intrepid virologist and BioCrowd co-founder, has been keeping folks up to date on the swine flu outbreak on his blog.
Bring patients together but it has to be on their terms
I just received some data from an online survey on social media and pharma that we are conducting for a client.
SWOT analysis - time for a product recall
Most of our plans and strategies contain a SWOT analysis, but the analysis, or at least what it has become is hardly worth the paper it is printed on. It is time to recall the SWOT analysis
Where does pharma go from here?
The recent problem of the auto industry here in the U.S. are nothing compared to the issues facing the pharmaceutical industry.
Balancing act - performance mangement versus molly coddling?
Carrot or stick? Which works best? When I review the various approaches to people management I struggle to conclude that one method is better than the other.
Why pharma marketers should own swine flu
I didn't want to write this post, but too many people have now asked, "where can I read your take on the swine flu?" Just to be different, I've refused to write anything, but now I've got to.
New era, same questions new quandary
by Anonymous (not verified)
Changing and revitalizing American graduate education in the life sciences
by Clifford M
Over the past several years, I have publicly called for fundamental changes in graduate education and training for life scientists.
The Monthly Forecasting Meeting: - Measuring Forecast Accuracy
by Alec Finney
The topic is forecast accuracy. There are many ways we can measure this and many discussions focus on the maths rather than the insight.
Patient adherence: getting personal again
One of my Aunts from Trinidad passed away a few years ago, she died from a diabetic complication, but which mainly stemmed from a lack of knowledge and understanding in managing her condition.
Pfizer And UCL Team Up To Develop Stem Cell Based Therapies
I was excited to hear the announcement at the weekend that Pfizer has engineered a partnership agreement with University College London.
Social Media and Career Development for Life Scientists
by Clifford M
Unlike others, life scientists have been slow to use social media to look for jobs or network to enhance career opportunities.